KB Financial Group, Inc. vs Novartis AG — how do they compare? KB Financial Group, Inc. trades at $115.25 (market cap $38.56B), while Novartis AG trades at $153.88 (market cap $290.25B). The key difference: Novartis AG is far larger — about 7.5× KB Financial Group, Inc.'s market cap, and Novartis AG pays the higher dividend (3.17%). Which is the better fit depends on your goals.
| KB | NVS | |
|---|---|---|
Market Cap | $38.56B | $290.25B |
Sector | Financials | Health |
52-Week High | $123.25 | $168.62 |
52-Week Low | $77.50 | $113.50 |
Dividend Yield | 2.72% | 3.17% |
Enterprise Value | — | $330.27B |
Trailing returns across standard periods
Latest headlines on both assets
KB Financial is the parent company of KB Kookmin Bank, Korea's largest commercial bank, with a 13.1% share of loans as of 2021. Its predecessor banks were established in the 1960s as government policy banks and privatized in the 1990s. Its credit card subsidiary KB Kookmin Card is the number-three player behind Shinhan Card and Samsung Card. KB has in recent years expanded its nonbank business by buying LIG Insurance and Hyundai Securities, making KB a top-five player in nonlife insurance and in securities, and most recently by buying Prudential Life Insurance Korea. It also has KB Capital, which provides leasing and installment finance.
Read more on KB →Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →